Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia

NCT00046930 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

449

Enrollment

NETWORK

Sponsor class

Conditions

Leukemia
Myelodysplastic Syndromes

Interventions

BIOLOGICAL: filgrastim
BIOLOGICAL: sargramostim
DRUG: cytarabine
DRUG: daunorubicin hydrochloride
DRUG: zosuquidar trihydrochloride
DRUG: Placebo

Sponsor

Eastern Cooperative Oncology Group

Collaborators

[object Object]
[object Object]
[object Object]